Cyclic AMP, Urine
Cyclic AMP (adenosine-3'-5'-monophosphate) acts as an intracellular "second messenger" that regulates the activity of various hormones including parathyroid hormone (PTH), adrenaline, epinephrine, Adrenocorticotropic Hormone (ACTH), Luteinizing Hormone (LH), Follicle-stimulating Hormone (FSH), glucagon, and calcitonin within the cell. The molecule itself is derived from adenosine triphosphate (ATP) which is a first messenger, binding to specific membrane receptors of hormone-responsive cells. This binding leads to the activation of an enzyme called adenylate cyclase, which begins the synthesis of cAMP from ATP. The increased intracellular level of cAMP initiates the activation of protein kinase A (PKA). Protein Kinase A is typically inactive as a tetramic holoenzyme consisting of two catalytic and two regulatory units. Under normal conditions the regulatory units block the catalytic units. cAMP binds to the regulatory units allowing the catalytic units to function by modifying certain proteins via a phosphorylating process. The measurement of cAMP in urine and/or plasma is becoming increasingly recognized for its role in the assessment of parathyroid functions.
An illustration of the role of cAMP (in its nephrogenic form) is shown in hyperparathyroidism with a prevalence of approximately 90% of all patients with the disease. Parathyroid hormone (PTH) stimulates the synthesis of cAMP in the renal cortex and an increased secretion of cAMP. The determination of cAMP is also significant for the differential diagnosis of hypercalcemia. An additional function of cAMP is the regulation of the passage of calcium ions through the ion channels of the cell. Testing for cAMP is performed from plasma and urine. Measurement of urinary cyclic AMP is an index of parathyroid function.
- As an aid in diagnosis of pseudohypoparathyroidism (type I and II)
- As an aid in diagnosis of primary hyperparathyroidism
- Evaluation of parathyroid function
- As an aid in diagnosis of secondary hyperparathyroidism in patients following jejunoileal bypass
- As an aid in diagnosis of hypercalcemia
- Might be useful for predicting the risk of recurrent renal stone
Increased in:
- Type I pseudohypoparathyroidism
- Type II pseudohypoparathyroidism
- Primary Hyperparathyroidism
- Secondary Hyperparathyroidism (Hypocalcemic states)
- Some patients with Vitamin D Deficiency
- Osteomalacia
- Trauma/Surgery
- Renal failure/Ureia
- Subarachnoid hemorrhage
- Acute myocardial infarction
- Hyperthyroidism, untreated
- Certain hormones including glucagon and norepinephrine
- Lithium therapy
- Manic phase of manic-depression.
Decreased in:
- Primary hypoparathyroidism
- Autoimmune hypoparathyroidism
- Hypercalcemia other than Primary Hyperparathyroidism
- Malignancy-Associated Hypercalcemia
- Calcium Urolithiasis
- Hypercalcemia not associated with primary hyperparathyroidism
- Moderate cerebral hemorrhage
Note: To calculate nephrogenous cAMP use this formula:
Total Urinary cAMP (nmol/100mL GF) = Serum Creatinine (mg/dL) x Urinary cAMP (nmol/mg Creatinine)
Nephrogenous cAMP (nmol/100mL GF) = Total Urinary cAMP (nmol/100mL GF) - Plasma cAMP (nmol/dL)
GF = Glomerular Filtrate
| Sex | ng/mL | nmol/L |
| Male | 4.6-83.6 | 14-26 |
| Female | 4.3-7.6 | 13-23 |
ELISA, EIA, HPLC/MS.
Urinary Specimen: Usually two-hour urine specimen is collected. Collect urine in a plastic container with no preservatives. Measure and document volume and then sample out in the 15mL sterile tube and freeze immediately.
2-7 days.
- J Clin Endocrinol Metab. 2011 Oct;96(10):3020-30. [PMID: 21816789]
- Nephron. 1979; 23:136-41. [PMID: 220548]
- J Clin Endocrinol Metab. 1984; 58:480-7. [PMID: 6319454]
- J Immunol Methods. 1992; 155(1):31-40. [PMID: 1328396]
- Anal Chem. 1989; 61(5):447-53. [PMID: 2541635]
- Calcif Tissue Int. 1998; 62(3):250-4. [PMID: 9501959]
- Strange RC et al. Plasma cyclic AMP and total catecholamines in man during acute myocardial infarction in man. European J of Clin Investigation. Apr 1974; 4(2): 115-119.
- Cocks RA et al. Increased plasma free cyclic-AMP levels following major trauma and their relevance to the immune response. Resuscitation. July 2000;45(2): 105-109.
- Buckley DE et al. Cyclic AMP Levels in Blood Cells from a short-cycle manic-depressive subject. Brit J Psychiat. 1980; 136:584-590.
- Kaminsky NI et al. Effects of Parathyroid Hormone on Plasma and Urinary Adenosine 3’,5’-Monophosphate in man. The Journal of Clinical Investigation (JCI). 1970; 49: 2387-2395.
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757